A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/09 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2714444
The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia- related or cardiovascular side effect.
L'invention porte sur des utilisations et des régimes d'administration de doses d'un antagoniste de l'hormone libérant la gonadotrophine (GnRH) pour un traitement sans danger et efficace du cancer de la prostate androgène-dépendant sans provoquer de pic de testostérone et/ou d'autres effets secondaires d'une thérapie par agoniste de GnRH, tels qu'une infection du tractus urinaire, ou un effet secondaire apparenté à l'arthralgie ou cardiovasculaire.
Cantor Per
Jensen Jens-Kristian Slott
Olesen Tine Kold
Persson Bo-Eric
Van Der Meulen Egbert A.
Ferring International Center Sa
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Method of treating prostate cancer with the gnrh antagonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating prostate cancer with the gnrh antagonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating prostate cancer with the gnrh antagonist... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1764586